CEL-SCI Corporation (CVM) |
|
3.01 -0.03 (-0.99%)
|
03-25 14:22 |
|
Open: |
3.02 |
Pre. Close: |
3.04 |
|
High:
|
3.1427 |
Low:
|
2.97 |
|
Volume:
|
261,362 |
Market Cap:
|
89M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.173 - 3.191 |
3.191 - 3.205 |
|
Low:
|
2.969 - 2.99 |
2.99 - 3.008 |
|
Close:
|
3.008 - 3.04 |
3.04 - 3.067 |
|
|
|
Technical analysis |
as of: 2019-03-25 1:58:53 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 3.94 One year: 4.60 |
| Support: |
Support1: 2.75 Support2: 2.37 |
| Resistance: |
Resistance1: 3.37 Resistance2: 3.94 |
| Pivot: |
2.99  |
| Moving Average: |
MA(5): 3.11 MA(20): 2.92
MA(100): 2.92 MA(250): 2.58 |
| MACD: |
MACD(12,26): 0.07 Signal(9): 0.06 |
| Stochastic oscillator: |
%K(14,3): 65.62 %D(3): 76.06 |
| RSI: |
RSI(14): 53.86 |
| 52-week: |
High: 4.44 Low: 0.82 Change(%): 107.6 |
| Average Vol(K): |
3-Month: 28134 10-Days: 26266 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.CVM has closed below upper band by 44.8%. Bollinger Bands are 26.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Sat, 19 Jan 2019 19:23:00 Z
Trial & Error: The Changing Landscape Of Cancer
Tue, 11 Sep 2018 16:47:57 Z
3 Small Biotech Stocks That Almost Doubled in Past Month
Fri, 07 Sep 2018 14:11:51 Z
Has Cel-Sci (CVM) Outpaced Other Medical Stocks This Year?
Fri, 31 Aug 2018 02:54:25 Z
Thursday Sector Leaders: Medical Instruments & Supplies, Biotechnology Stocks
Wed, 27 Jun 2018 20:08:02 Z
Wednesday Sector Laggards: Biotechnology, Drugs
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
